ROCKVILLE, Md., Dec. 11, 2015 (GLOBE NEWSWIRE) -- The Regulatory Affairs Professionals Society (RAPS) announced today the retirement of its Executive Director Sherry Keramidas whose leadership during a 20-year tenure helped advance the healthcare regulatory profession. She will retire on 31 January 2016.
"Sherry has served RAPS and its members during a critical period of change in the healthcare industry," according to RAPS Chairman of the Board Rainer Voelksen. "Her constancy throughout ensured RAPS' mission to provide leading education and professional development opportunities and credentialing to regulatory professionals. The RAPS Board of Directors extends its deepest appreciation to Sherry for her two decades of stewardship and commitment to RAPS members, partners and Board."
"It's been my pleasure to serve RAPS during a period of unprecedented change in the healthcare industry," said Keramidas. "The regulatory environment will continue to rapidly evolve and I retire from RAPS confident that the advancement of its professionals will continue to be the defining commitment of this organization's leadership."
The Board's top priority during the transition to new leadership is to ensure RAPS' continuity in fulfilling day-to-day operations that deliver on the organization's commitment to programming and other essential functions that serve its members and partners. Sherry will help facilitate the transition by working with the Executive Committee of the Board to provide support on specific key initiatives.
The Board has initiated a search for a new executive director and will be announcing a plan for interim leadership in the coming weeks. It has established a Search Committee of the Board and will engage a professional recruiting firm to conduct the search for the permanent executive director.
With questions or for more information, please contact RAPS President Martha A. Brumfield at [email protected].
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with offices in Shanghai and Singapore, and chapters and affiliates worldwide. RAPS.org
CONTACT: Zachary Brousseau
Senior Manager, Communications
RAPS
+1 301 770 2920, ext. 245; [email protected]


SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws 



